Last reviewed · How we verify
NCT03210194: RCPNEOPERU
Randomized Cluster Trial on Innovative and Standard Strategies for Neonatal Resuscitation Training (RCPNEOPERU Project)
NA trial testing Standard Neonatal Resuscitation Training in Neonatal Asphyxia in 12 participants. Completed in 7 September 2018.
31 August 2018
Quick facts
| Lead sponsor | Universidad Peruana Cayetano Heredia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 12 |
| Start date | 1 April 2017 |
| Primary completion | 31 August 2018 |
| Estimated completion | 7 September 2018 |
| Sites | 1 location across Peru |
Drugs / interventions tested
- Standard Neonatal Resuscitation Training
- MP-ICT Neonatal Resuscitation Training
Conditions studied
- Neonatal Asphyxia — all drugs for Neonatal Asphyxia →
Sponsor
Universidad Peruana Cayetano Heredia — full company profile →
Who can join
Eligibility, any sex, with Neonatal Asphyxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: About 10% of all newborns may have difficulty breathing and require support by trained personnel. In Peru, 90% of deliveries occur in health facilities; however there is not a national neonatal resuscitation and certification program for the public health sector. In addition, the Andes and the Amazon regions concentrate large rural remote areas, which further limit the implementation of training programs and the accomplishment of continuous certification. Neonatal resuscitation training through the use of information, communication and technology (ICT) tools running on a computer, tablet or mobile phone may overcome such limitations. This strategy allows online and offline access to educational resources, paving the way to more frequent and efficient training and certification processes. Objective: To evaluate the effects of a neonatal resuscitation training and certification program that uses a multi-platform ICT (MP-ICT) strategy on neonatal health care in remote areas. Methods: The investigators propose to conduct the study through a cluster-randomized trial, where the study and analysis units are the health care facility. Eligible facilities will include primary and secondary health care level facilities that are located in provinces with neonatal mortality rates higher than 15 per 1,000 live births. The investigators will compare the proportion of newborns with a heart rate ≥100 beats per minute at 2 minutes after birth in health care facilities that receive MP-ICT training and certification implementation, with those that receive conventional training and certification. Discussion: The investigators expect that the intervention show to be more effective than the current standard of care. The investigators are prepared to include it within a national neonatal resuscitation training and certification program to be implemented at national scale together with policymakers and other key stakeholders.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Continuous training and certification in neonatal resuscitation in remote areas using a multi-platform information and communication technology intervention, compared to standard training: A randomized cluster trial study protocol.
Delgado CA, Gómez Pomar EM, Velásquez P, Sánchez V, et al · · 2017 · cited 3× · PMID 30026911 · DOI 10.12688/f1000research.12269.3 -
RCPNEOPERU trial: a cluster randomized pilot trial to assess traditional neonatal resuscitation compared to partially virtual training in remote areas.
Delgado CA, Gómez Pomar E, Velásquez P, Sánchez V, et al · · 2025 · cited 1× · PMID 40441272 · DOI 10.1016/j.jped.2025.04.008 -
Continuous training and certification in neonatal resuscitation in remote areas using a multi-platform information and communication technology intervention, compared to standard training: A randomized cluster trial study protocol
Delgado CA, Gómez Pomar EM, Velásquez P, Sánchez V, et al · · 2018 · DOI 10.12688/f1000research.12269.3
Verify or expand the search:
- PubMed search for NCT03210194
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universidad Peruana Cayetano Heredia trials
Trials by the same sponsor.
- NCT06367361 — One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis · Phase 2 · not yet recruiting
- NCT06989502 — Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries · NA · not yet recruiting
- NCT06565507 — Oxfendazole in Mild Parenchymal Brain Cysticercosis · Phase 2, PHASE3 · not yet recruiting
- NCT05981378 — Genomic Approaches to Dissect Human Host-pathogen Interactions in the Amazonian Rainforest · not yet recruiting
- NCT06500013 — WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03210194 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Peruana Cayetano Heredia
- Last refreshed: 7 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03210194.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing